Feature Channels: Allergies

Filters close
Released: 6-Dec-2022 11:50 AM EST
Itchy Eyes and a Runny Nose? It Could Be Climate Change
Rutgers University-New Brunswick

Researchers with the Rutgers Environmental and Occupational Health Sciences Institute have simulated how climate change will affect the distribution of two leading allergens – oak and ragweed pollens – across the contiguous United States. The results, published in the journal Frontiers in Allergy, may make your eyes water.

Released: 5-Dec-2022 7:40 PM EST
Scientists find inorganic food additives might make babies more vulnerable to allergies
Frontiers

Nanotechnologies have revolutionized food technology with changes to food production, manufacture, and processing that are intended to make our food safer and healthier.

Newswise: Allergies and Asthma Shouldn’t Prevent Comfort and Joy this Holiday Season
Released: 17-Nov-2022 8:00 AM EST
Allergies and Asthma Shouldn’t Prevent Comfort and Joy this Holiday Season
American College of Allergy, Asthma and Immunology (ACAAI)

Keep allergy and asthma triggers top of mind as you map out what your holidays will look like this year.

Newswise: Tiny molecules in breast milk may prevent infants from developing allergies
Released: 15-Nov-2022 12:00 PM EST
Tiny molecules in breast milk may prevent infants from developing allergies
Penn State College of Medicine

A new study by Penn State College of Medicine finds that small molecules found in most humans’ breast milk may reduce the likelihood of infants developing allergic conditions.

Newswise: El tratamiento CRISPR reduce la inflamación en pacientes con angioedema hereditario
4-Nov-2022 8:00 AM EDT
El tratamiento CRISPR reduce la inflamación en pacientes con angioedema hereditario
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año muestra que un tratamiento que usa una tecnología de edición genética de repeticiones palindrómicas cortas, agrupadas y regularmente interespaciadas logró aliviar la inflamación y reducir la frecuencia de los ataques.

Newswise: CRISPR Treatment Slows Swelling in Hereditary Angioedema Patients
4-Nov-2022 8:00 AM EDT
CRISPR Treatment Slows Swelling in Hereditary Angioedema Patients
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting shows a treatment using the CRISPR genome editing technology succeeded in alleviating swelling and reducing the frequency of attacks.

Newswise: Smartphones are Reservoirs of Allergens According to New Research
4-Nov-2022 8:00 AM EDT
Smartphones are Reservoirs of Allergens According to New Research
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting in Louisville, KY, showed elevated levels of cat and dog allergens, as well as β-D glucans (BDG) and endotoxin on simulated phone models.

Newswise: Los recuentos de polen más bajos se producen entre las 4:00 a. m. y el mediodía
4-Nov-2022 8:00 AM EDT
Los recuentos de polen más bajos se producen entre las 4:00 a. m. y el mediodía
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año sugiere que las primeras horas de la mañana son mejores que las últimas de la tarde para evitar el polen.

Newswise: Los teléfonos inteligentes son depósitos de alérgenos
4-Nov-2022 8:00 AM EDT
Los teléfonos inteligentes son depósitos de alérgenos
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión Científica Anual del ACAAI de este año muestra niveles elevados de alérgenos de gatos y perros, así como de glucanos β-D y endotoxinas en modelos telefónicos simulados.

Newswise: Even in States with Strong Stock Albuterol Laws, School Administrators Fear Liability
4-Nov-2022 8:00 AM EDT
Even in States with Strong Stock Albuterol Laws, School Administrators Fear Liability
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that even in states with strong stock inhaler/albuterol laws, school administrators and prescribing clinicians fear liability in prescribing and administering the stock inhalers.

Newswise: Lowest Pollen Counts Occur Between 4:00 a.m. and Noon
4-Nov-2022 8:00 AM EDT
Lowest Pollen Counts Occur Between 4:00 a.m. and Noon
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting suggests that early morning hours are better than later in the afternoon for dodging pollen.

Newswise: Solo al 52 % de los adultos con alergia grave a los alimentos se le ha prescrito un autoinyector de epinefrina
4-Nov-2022 8:00 AM EDT
Solo al 52 % de los adultos con alergia grave a los alimentos se le ha prescrito un autoinyector de epinefrina
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI muestra que solo la mitad de los pacientes adultos alérgicos a los alimentos tienen acceso inmediato a la epinefrina y que el 36 % de los adultos creen que los autoinyectores de epinefrina pueden causar efectos negativos o potencialmente mortales.

Newswise: Only 52% of Adults with Severe Food Allergy Have Been Prescribed an Epinephrine Auto Injector
4-Nov-2022 8:00 AM EDT
Only 52% of Adults with Severe Food Allergy Have Been Prescribed an Epinephrine Auto Injector
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that only half of food allergic adult patients have immediate access to epinephrine, and 36% of adults believe epinephrine auto injectors can cause negative or life-threatening effects.

Newswise: 86.4 % de los bebés con anafilaxia recibieron epinefrina de manera adecuada
4-Nov-2022 8:00 AM EDT
86.4 % de los bebés con anafilaxia recibieron epinefrina de manera adecuada
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presentó en la Reunión Científica Anual del ACAAI de este año muestra que de los bebés de 0 a 24 meses que acudieron al servicio de urgencias por anafilaxia, pocos requirieron hospitalización y la mayoría pudo irse a casa después de unas horas de observación.

Newswise: Study Shows 86.4% of Infants with Anaphylaxis Appropriately Received Epinephrine
4-Nov-2022 8:00 AM EDT
Study Shows 86.4% of Infants with Anaphylaxis Appropriately Received Epinephrine
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that, in infants aged 0-24 months who presented to the emergency department for anaphylaxis, few required hospitalization and most were able to go home after a few hours of observation.

2-Nov-2022 10:15 AM EDT
Managing Eczema in Babies: Five Things to Know
McMaster University

Five key messages for general and specialist care providers, as well as caregivers, promote best practices for managing atopic dermatitis in infants.

Newswise: Research team discovers central functions of innate immune cells
Released: 3-Nov-2022 3:05 AM EDT
Research team discovers central functions of innate immune cells
Charité - Universitätsmedizin Berlin

Inflammation and increased mucus production are typical symptoms of worm infections and allergies. This immune response involves our innate immune cells, but their exact functions are not yet fully understood.

Released: 25-Oct-2022 2:10 PM EDT
The latest news in Opioids, Drug Abuse, and Addiction
Newswise

Here are some of the latest articles that have been added to the Drugs and drug abuse channel.

Newswise: Chemist examines properties of tattoo inks
Released: 17-Oct-2022 2:05 PM EDT
Chemist examines properties of tattoo inks
Binghamton University, State University of New York

Researchers at Binghamton University, State University of New York are working to understand the molecular composition of tattoo inks to provide knowledge to artists and consumers.

Newswise: Trick-Or-Treat Tips — Johns Hopkins Children’s Center Experts Available to Talk About Halloween Safety
Released: 13-Oct-2022 8:00 AM EDT
Trick-Or-Treat Tips — Johns Hopkins Children’s Center Experts Available to Talk About Halloween Safety
Johns Hopkins Medicine

It’s that time of year: costumes, candy and trick-or-treating. As families celebrate this season, Johns Hopkins Children’s Center experts are available for interviews on a variety of tips to help ensure a safe and fun Halloween.

Newswise: Children with Food Allergy-Related Anxiety Can Benefit from Cognitive Behavioral Therapy
Released: 4-Oct-2022 8:00 AM EDT
Children with Food Allergy-Related Anxiety Can Benefit from Cognitive Behavioral Therapy
American College of Allergy, Asthma and Immunology (ACAAI)

A new study in Annals of Allergy, Asthma and Immunology shows that targeted cognitive behavioral therapy (CBT) can significantly lessen food allergy-related anxiety (FAA) for both children and parents.

Newswise: Protecting Children from Eye Allergies May Be as Simple as Encouraging Physical Fitness
Released: 30-Sep-2022 8:05 AM EDT
Protecting Children from Eye Allergies May Be as Simple as Encouraging Physical Fitness
American Academy of Ophthalmology (AAO)

Researchers found that children who were more physically fit were less likely to develop allergic conjunctivitis.

Released: 28-Sep-2022 3:10 PM EDT
CHOP’s Food Allergy Bravery Clinic Helps Kids with Food Allergies Overcome Anxiety
Children's Hospital of Philadelphia

A new study in the Annals of Allergy, Asthma & Immunology shows that a first-of-its-kind program at Children’s Hospital of Philadelphia (CHOP) can help children with food allergy-related anxiety reduce their fears and improve their quality of life. The Food Allergy Bravery (FAB) program at CHOP provides cognitive behavioral therapy (CBT) in five to eight sessions to children who have severe anxiety related to their food allergies.

Newswise: Create Halloween Scares That Are Safe and Fun for Kids with Allergies and Asthma
Released: 28-Sep-2022 8:00 AM EDT
Create Halloween Scares That Are Safe and Fun for Kids with Allergies and Asthma
American College of Allergy, Asthma and Immunology (ACAAI)

It’s best not to combine Halloween scares with allergy and asthma flares. ACAAI has tips for making Halloween safe and fun for kids with allergies and asthma.

Released: 27-Sep-2022 10:45 AM EDT
How to tell the difference between dry hands and hand eczema
American Academy of Dermatology

Hand eczema is one of the most common forms of eczema, causing dry, itchy, and irritated skin affecting the whole hand, including the fingers. This skin condition can negatively impact a person’s quality of life because we use our hands often. In recognition of Eczema Awareness Month in October, board-certified dermatologists share information about the causes of hand eczema and how it can be treated to keep the condition from worsening.

Released: 7-Sep-2022 3:15 PM EDT
Five Reasons You Should Attend the First Ever Joint CSACI-ACAAI Conference
American College of Allergy, Asthma and Immunology (ACAAI)

The Canadian Society of Allergy and Clinical Immunology (CSACI) and the American College of Asthma, Allergy and Immunology (ACAAI) are partnering for the first-ever North American Pediatric Allergy and Asthma Congress (NAPAAC).

Newswise:Video Embedded navigating-your-pathway-to-better-sinus-health
VIDEO
Released: 6-Sep-2022 1:05 PM EDT
Navigating Your Pathway to Better Sinus Health
American Academy of Otolaryngology - Head and Neck Surgery

Providing accessible public and patient information that will assist individuals in understanding their own individual journey to better sinus health.

Released: 22-Aug-2022 3:45 PM EDT
Find expert commentary on the monkeypox outbreak here
Newswise

The latest research and expert commentary on the monkeypox outbreak.

15-Aug-2022 11:45 PM EDT
Food allergies can be reversed in mice by targeting the microbiome
American Chemical Society (ACS)

Treating allergic mice with a form of butyrate — which is produced by good gut bacteria — protects against peanut allergy, scientists report today. The treatment might also counteract other food allergies and inflammatory diseases. They will present their results at ACS Fall 2022.

   
Newswise: There is Breaking News You Haven’t Heard Regarding Allergies and Asthma
Released: 19-Aug-2022 11:20 AM EDT
There is Breaking News You Haven’t Heard Regarding Allergies and Asthma
American College of Allergy, Asthma and Immunology (ACAAI)

Media are invited to pre-register for the ACAAI Annual Scientific Meeting in Louisville, KY, November 10-14.

Newswise: New Study: 36% of YouTube Videos Contain Misleading Hay Fever Information
Released: 10-Aug-2022 9:50 AM EDT
New Study: 36% of YouTube Videos Contain Misleading Hay Fever Information
American College of Allergy, Asthma and Immunology (ACAAI)

A new study in Annals of Allergy, Asthma and Immunology showed misleading content regarding hay fever on YouTube generated a higher amount of user interaction in terms of likes and comments than videos with useful content.

Released: 9-Aug-2022 1:45 PM EDT
Consider yourself a foodie? Dig into these latest headlines from the Food Science channel
Newswise

Below are some of the latest articles that have been added to the Food Science channel on Newswise, a free source for journalists.

       
Released: 5-Aug-2022 2:30 PM EDT
Ragweed allergy: aggressiveness of pollen is determined by its place of origin and by the environment
Medical University of Vienna (MedUni Wien)

The different geographic and climatic regions from which ragweed pollen originates, as well as the degree of environmental pollution, may influence the severity of allergic reactions such as hay fever and asthma.

   
Released: 4-Aug-2022 5:05 PM EDT
Houston Methodist study finds new chronic rhinitis treatment could be game changer
Houston Methodist

A new study at Houston Methodist shows that that a new temperature-controlled radiofrequency intervention is a safe and effective way to improve symptoms of chronic rhinitis. Chronic rhinitis involves symptoms such as a near constant runny nose, congestion, as well as nasal and throat itching and sneezing. In addition to costing billions of dollars each year in healthcare costs, the associated symptoms have significant and severe impacts on people’s quality of life and ability to go about day-to-day activities.

Released: 4-Aug-2022 9:30 AM EDT
Newly Discovered “Danger Signal” May Spur Vaccine Development and Allergy Treatment
Rutgers University-New Brunswick

A team of Rutgers researchers and others inject parasitic worms into mice to study how injured cells trigger an immune response.

Released: 29-Jul-2022 2:05 PM EDT
Don't give up the fight. Read the latest news about drug and antibiotic resistance
Newswise

Here are some of the latest articles that have been added to the Drug Resistance channel on Newswise, a free source for journalists.

Released: 28-Jul-2022 11:05 AM EDT
Early Exposure to Antibiotics Can Cause Permanent Asthma and Allergies
Rutgers University-New Brunswick

Early exposure to antibiotics kills healthy bacteria in the digestive tract and can cause asthma and allergies, a new study demonstrates.

Released: 25-Jul-2022 2:05 PM EDT
KSL Biomedical, Inc. to Exhibit at AACC Annual Scientific Meeting + Clinical Lab Expo
2022 AACC Annual Scientific Meeting Press Program

The premier global laboratory medicine exposition to be held at the McCormick Place Convention Center in Chicago, July 24-28, 2022.

Released: 20-Jul-2022 10:50 AM EDT
Adjusting diet has pros and cons for treating eczema, study says
McMaster University

People with mild or moderate eczema may gain some relief from their condition by adjusting their diets, but there are important downsides that make diets for eczema not a choice to take lightly, says McMaster University researcher Derek Chu.

11-Jul-2022 4:45 PM EDT
Costs for Emergency Allergy Injectors Still High for Some?
Michigan Medicine - University of Michigan

People with severe allergies now have more choices for which epinephrine auto-injector to carry in case they suffer a life-threatening attack, and most pay less for it than they did when the EpiPen was the primary option, a new study shows. But for a significant minority, the amount they pay has stayed high – largely due to their health insurance plans.

Newswise: Celebrate Stars and Stripes Minus Allergy and Asthma Symptoms
Released: 23-Jun-2022 8:30 AM EDT
Celebrate Stars and Stripes Minus Allergy and Asthma Symptoms
American College of Allergy, Asthma and Immunology (ACAAI)

Start preparing now to make your 4th of July holiday allergy and asthma-free.

Newswise: Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
Released: 21-Jun-2022 8:00 AM EDT
Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
University of California, San Francisco (UCSF)

Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.

Released: 14-Jun-2022 3:15 PM EDT
"Yes, optimists live longer" and more research news on Aging for media
Newswise

Here are some of the latest articles that have been added to the Aging channel on Newswise, a free source for journalists.

       
Newswise: Turn Down the Heat on Summer Allergies
Released: 8-Jun-2022 8:30 AM EDT
Turn Down the Heat on Summer Allergies
American College of Allergy, Asthma and Immunology (ACAAI)

Allergy and asthma symptoms can feel particularly out of control during summer months. The American College of Allergy, Asthma and Immunology offer tips on how to keep symptoms in check.

Newswise: Food allergy is associated with lower risk of SARS-CoV-2 infection
Released: 1-Jun-2022 3:15 PM EDT
Food allergy is associated with lower risk of SARS-CoV-2 infection
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

A National Institutes of Health-funded study has found that people with food allergies are less likely to become infected with SARS-CoV-2, the virus that causes COVID-19, than people without them.



close
1.51114